18:57 EDT Cogent Biosciences files to sell 31.2M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COGT:
- Cogent Biosciences price target raised to $19 from $13 at H.C. Wainwright
- Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Cogent Biosciences expects cash to fund requirements into 2027
- Cogent Biosciences reports Q4 EPS (63c), consensus (55c)
- Cogent Biosciences price target raised to $13 from $11 at Citi